Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Umbilical Cord Blood Stem Cells As Third-Party Adjuvant Infusion in Human Leukocyte Antigen Antibody-Positive Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Yujie Jiang, Yuying Wang, Dai Yuan, Xiaosheng Fang, Huiting Qu, Lingyan Zhang, Ying Li, Xin Wang

Blood (2023) 142 (Supplement 1): 6911.

https://doi.org/10.1182/blood-2023-182905

Published: 2023

Journal Articles

Orelabrutinib in Combination with Rituximab and Chemotherapy for Newly Diagnosed Aggressive B-Cell Lymphoma: A Multicenter, Single-Arm, Prospective Study

Blood (2022) 140 (Supplement 1): 9544–9545.

https://doi.org/10.1182/blood-2022-169274

Published: 2022

Journal Articles

Comprehensive Profile of Young and Elderly Chronic Lymphocytic Leukemia Patients in China: The Younger Population Compared with Western Countries

Zheng Tian, Ming Liu, Ying Li, Lingyan Zhang, Xiaosheng Fang, Xiangxiang Zhou, Peipei Li, Ya Zhang, Xin Wang

Blood (2021) 138 (Supplement 1): 3745.

https://doi.org/10.1182/blood-2021-146818

Published: 2021

Journal Articles

Comprehensive Profiling of the Epitranscriptomic N6-Methyladenosine RNA Methylation in Chronic Lymphocytic Leukemia

Ya Zhang, MD, Xinting Hu, MM, Hongzhi Xu, MD, Ying Li, MD, Lingyan Zhang, MD, Lili Feng, MD, Xiangxiang Zhou, MD, Xiaosheng Fang, MD PhD, Yujie Jiang, MD, Mei Ding, MD, Jianhong Wang, Xin Wang, MDPhD

Blood (2020) 136 (Supplement 1): 17–18.

https://doi.org/10.1182/blood-2020-141758

Published: 2020

Journal Articles

Hyperbaric Oxygen Therapy Improve Acute Graft-Versus-Host Disease By Activating the Nrf2/HO-1 Pathway in a Mice Model

Chao Xue, Qian Zhang, Hao Chen, Dai Yuan, MD, Xin Wang, MDPhD, Xiao Lv, PhD, Xueling Ge, PhD, Kang Lu, PhD, Lingyan Zhang, MD, Yujie Jiang, MD

Blood (2020) 136 (Supplement 1): 49.

https://doi.org/10.1182/blood-2020-141864

Published: 2020

Journal Articles

Hyperbaric Oxygen Therapy for Late-Onset Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation and Effective Factors Prediction

Yujie Jiang, MD, Hao Chen, Xiaosheng Fang, MD PhD, Xiaohui Sui, Chao Xue, Huiting Qu, Mei Ding, Changqing Zhen, Qian Zhang, Ying Li, MD, Hongzhi Xu, MD, Lingyan Zhang, MD, Xin Wang, MDPhD

Blood (2020) 136 (Supplement 1): 27–28.

https://doi.org/10.1182/blood-2020-136891

Published: 2020

Journal Articles

Bioinformatics Analysis of Differently Expressed Mirnas in CD5 Positive Relapsed and Refractory Diffuse Large B-Cell Lymphoma and Their Potential Theoretical and Clinical Investigations

Qian Zhang, Chao Xue, Xin Wang, MDPhD, Kang Lu, PhD, Xueling Ge, PhD, Xiao Lv, PhD, Lingyan Zhang, MD, Hongzhi Xu, MD, Yujie Jiang, MD

Blood (2020) 136 (Supplement 1): 2–3.

https://doi.org/10.1182/blood-2020-141919

Published: 2020

Journal Articles

Clinical, Hematological, Genetic, and Pathological Significance in Newly Diagnosed High Grade B-Cell Lymphoma and Diffuse Large B-Cell Lymphoma

Qingyuan Qu, Lingyan Zhang, Chao Xue, Xueling Ge, PhD, Xiao Lv, Kang Lu, MD PhD, Xin Wang, MD PhD, Yujie Jiang, MD

Blood (2019) 134 (Supplement_1): 5339.

https://doi.org/10.1182/blood-2019-129629

Published: 2019

Journal Articles

A Randomized Controlled Clinical Study of Peg-Rhg-CSF for Preventing Chemotherapy-Induced Neutropenia in Patients with B-Cell Non-Hodgkin Lymphoma

Changqing Zhen, MD, Mei Ding, Kang Lu, MD PhD, Xueling Ge, PhD, Na Chen, MD, Xiaosheng Fang, MD, Xiaohui Sui, Jiang Yujie, MD, Xin Liu, Ying Li, Xianghua Wang, Ying Li, MD, Lingyan Zhang, MD, Hongzhi Xu, Juan Fan, MD, Xin Wang, MD PhD

Blood (2019) 134 (Supplement_1): 5323.

https://doi.org/10.1182/blood-2019-128438

Published: 2019

Journal Articles

Responses and Cardiotoxicity with R-CDOP and R-CHOP Observed in Frontline Therapy for Patients with Primary Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL): A Randomized Phase-IV Study from Multiple Centers in China

Lili Feng, MD PhD, Xiaoxia Chu, Hongguo Zhao, MD, Yili Wang, Jie Li, Ying Li, MD, Xuehong Ran, Jie Min, Lingyan Zhang, MD, Hongzhi Xu, Jingxia Wang, Ling Wang, Yunliang Hao, Ruirong Xu, Juan Fan, MD, Lei Wang, Xin Wang, MD PhD

Blood (2018) 132 (Supplement 1): 2960.

https://doi.org/10.1182/blood-2018-99-116295

Published: 2018

Journal Articles

Pre-Treatment Derived Neutrophil to Lymphocyte Ratio As a Prognostic Factor in Extranodal Natural Killer/T-Cell Lymphoma

Xiangxiang Zhou, MD, Lingyan Zhang, MD, Ying Li, MD, Xiaosheng Fang, PhD, Xiao Lv, PhD, Kang Lu, PhD, Xin Wang, MD PhD

Blood (2018) 132 (Supplement 1): 5307.

https://doi.org/10.1182/blood-2018-99-115907

Published: 2018

Journal Articles

Prognostic Importance of DOCK1 Transcript Levels, and Biologic Insights from DOCK1 -Associated Gene and Microrna Expression Signatures in De Novo acute Myeloid Leukemia

Ya Zhang, MD, Ying Li, MD, Lingyan Zhang, MD, Xiaosheng Fang, MD, Changqing Zhen, MD, Xin Wang, MD PhD

Blood (2017) 130 (Supplement 1): 3952.

https://doi.org/10.1182/blood.V130.Suppl_1.3952.3952

Published: 2017

Journal Articles

SPTBN1-FLT3 in Atypical Chronic Myeloid Leukemia Transforms Ba/F3 Cells to IL-3 Independence and Is Sensitive to Both Tyrosine Kinase Inhibitors and Immunotherapy.

Francis H. Grand, PhD, Sameena Iqbal, BSc, Lingyan Zhang, MD, Nigel H. Russell, MD, Andrew Chase, PhD, Nicholas C.P. Cross, PhD

Blood (2005) 106 (11): 2009.

https://doi.org/10.1182/blood.V106.11.2009.2009

Published: 2005

Journal Articles

The Long-Lerm Follow-Up of Childhood Acute Lymphoblastic Leukemia Treated in China with Chemotherapy under Poor Coverage of Medical Insurance: A Single Center Experience.

Yongmin Tang, MD, Hua Song, MD, Shuwen Shi, MD, Shilong Yang, MD, Jian Wei, MD, Weiqun Xu, MD, Binhua Pan, MD, Yinghu Chen, MD, Lingyan Zhang, MD, Fenying Zhao, MD, Botao Ning, PhD, Xiaojun Xu, MS

Blood (2005) 106 (11): 4580.

https://doi.org/10.1182/blood.V106.11.4580.4580

Published: 2005

Journal Articles

Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders

Blood (2005) 106 (6): 2162–2168.

https://doi.org/10.1182/blood-2005-03-1320

Published: 2005

NARROW

Umbilical Cord Blood Stem Cells As Third-Party Adjuvant Infusion in Human Leukocyte Antigen Antibody-Positive Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Orelabrutinib in Combination with Rituximab and Chemotherapy for Newly Diagnosed Aggressive B-Cell Lymphoma: A Multicenter, Single-Arm, Prospective Study

Comprehensive Profile of Young and Elderly Chronic Lymphocytic Leukemia Patients in China: The Younger Population Compared with Western Countries

Comprehensive Profiling of the Epitranscriptomic N6-Methyladenosine RNA Methylation in Chronic Lymphocytic Leukemia

Hyperbaric Oxygen Therapy Improve Acute Graft-Versus-Host Disease By Activating the Nrf2/HO-1 Pathway in a Mice Model

Hyperbaric Oxygen Therapy for Late-Onset Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation and Effective Factors Prediction

Bioinformatics Analysis of Differently Expressed Mirnas in CD5 Positive Relapsed and Refractory Diffuse Large B-Cell Lymphoma and Their Potential Theoretical and Clinical Investigations

Clinical, Hematological, Genetic, and Pathological Significance in Newly Diagnosed High Grade B-Cell Lymphoma and Diffuse Large B-Cell Lymphoma

A Randomized Controlled Clinical Study of Peg-Rhg-CSF for Preventing Chemotherapy-Induced Neutropenia in Patients with B-Cell Non-Hodgkin Lymphoma

Responses and Cardiotoxicity with R-CDOP and R-CHOP Observed in Frontline Therapy for Patients with Primary Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL): A Randomized Phase-IV Study from Multiple Centers in China

Pre-Treatment Derived Neutrophil to Lymphocyte Ratio As a Prognostic Factor in Extranodal Natural Killer/T-Cell Lymphoma

Prognostic Importance of DOCK1 Transcript Levels, and Biologic Insights from DOCK1 -Associated Gene and Microrna Expression Signatures in De Novo acute Myeloid Leukemia

SPTBN1-FLT3 in Atypical Chronic Myeloid Leukemia Transforms Ba/F3 Cells to IL-3 Independence and Is Sensitive to Both Tyrosine Kinase Inhibitors and Immunotherapy.

The Long-Lerm Follow-Up of Childhood Acute Lymphoblastic Leukemia Treated in China with Chemotherapy under Poor Coverage of Medical Insurance: A Single Center Experience.

Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only